Sue Lightman Selected Research

Macular Degeneration (Age-Related Maculopathy)

11/2020	The prognostic value of total macular external limiting membrane and ellipsoid zone damage for clinical outcome in treatment-resistant neovascular age-related macular degeneration.
1/2018	'Statins in retinal disease'.
1/2017	Aflibercept improves outcome in eyes with poor vision from neovascular age-related macular degeneration.
1/2016	A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept.
9/2012	Rhizobium radiobacter Endophthalmitis following Intravitreal Ranibizumab Injection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sue Lightman Research Topics

Disease

36	Uveitis 01/2024 - 02/2006
16	Inflammation (Inflammations) 02/2021 - 07/2007
13	Cataract (Cataracts) 06/2022 - 07/2007
8	Macular Edema 09/2020 - 01/2011
7	Retinal Vein Occlusion 09/2020 - 01/2012
5	Posterior Uveitis 02/2021 - 02/2006
5	Macular Degeneration (Age-Related Maculopathy) 11/2020 - 09/2012
5	Anterior Uveitis 05/2020 - 02/2006
5	Glaucoma 05/2020 - 01/2012
4	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 10/2015 - 03/2009
3	Infections 01/2024 - 07/2012
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2018 - 12/2011
2	Choroidal Neovascularization 10/2023 - 01/2022
2	Endophthalmitis (Ophthalmia) 06/2022 - 09/2012
2	Vasculitis (Vasculitides) 01/2022 - 05/2017
2	Acute Retinal Necrosis Syndrome 01/2019 - 01/2018
2	Necrosis 01/2019 - 02/2006
2	Disease Progression 01/2018 - 01/2016
2	Retinal Detachment (Retinal Detachments) 01/2018 - 06/2012
2	Rheumatoid Arthritis 03/2017 - 02/2006
2	Hypertension (High Blood Pressure) 01/2016 - 07/2007
1	Orbital Myositis 01/2023
1	Eye Diseases (Eye Disease) 01/2022
1	Cytomegalovirus Retinitis 01/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019
1	Eye Infections 01/2018
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Retinal Diseases 01/2018
1	Latent Tuberculosis 01/2018
1	Toxic Optic Neuropathy 01/2018
1	Arthritis (Polyarthritis) 01/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2014
1	Multiple Sclerosis 01/2014
1	Ischemia 01/2014
1	Retinal Vasculitis 01/2014
1	Neovascular Glaucoma 05/2013
1	Scleritis (Episcleritis) 09/2012
1	Bronchiolitis Obliterans Syndrome 07/2012
1	Rhinitis 01/2012
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2012
1	Orbital Diseases 01/2012

Drug/Important Bio-Agent (IBA)

15	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 07/2007
13	Retinaldehyde (Retinal)IBA 01/2022 - 11/2007
11	SteroidsIBA 09/2020 - 02/2006
9	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 01/2010
4	Prednisolone (Predate)FDA LinkGeneric 12/2023 - 05/2017
4	Ranibizumab (Lucentis)FDA Link 10/2023 - 09/2012
4	Bevacizumab (Avastin)FDA Link 10/2023 - 01/2014
3	Infliximab (Remicade)FDA Link 01/2023 - 02/2006
3	afliberceptIBA 11/2020 - 01/2016
3	Rituximab (Mabthera)FDA Link 06/2015 - 09/2012
2	Simvastatin (Zocor)FDA LinkGeneric 12/2023 - 03/2017
2	Endothelial Growth FactorsIBA 01/2022 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 09/2020
2	InterferonsIBA 09/2021 - 01/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 03/2017
2	Fluorescein (Funduscein)FDA LinkGeneric 05/2017 - 01/2014
2	Methotrexate (Mexate)FDA LinkGeneric 11/2013 - 04/2012
2	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 11/2011 - 01/2011
2	Triamcinolone (Aristocort)FDA Link 12/2010 - 07/2007
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2024
1	Immunomodulating AgentsIBA 12/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2022
1	Vancomycin FDA LinkGeneric 06/2022
1	E-SelectinIBA 01/2022
1	P-SelectinIBA 01/2022
1	PlasticsIBA 09/2021
1	GW559090IBA 02/2021
1	IntegrinsIBA 02/2021
1	Integrin alpha4beta1 (VLA-4)IBA 02/2021
1	Indicators and Reagents (Reagents)IBA 09/2020
1	rimexolone (Vexol)FDA Link 05/2020
1	SuspensionsIBA 05/2020
1	Adalimumab (Humira)FDA Link 01/2019
1	CytokinesIBA 01/2018
1	Valacyclovir (Valtrex)FDA LinkGeneric 01/2018
1	CholesterolIBA 01/2018
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2018
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 10/2015
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	Interleukin-23 (Interleukin 23)IBA 10/2015
1	Dihydrotachysterol (AT 10)IBA 12/2014
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2012
1	ProstaglandinsIBA 01/2012

Therapy/Procedure

18	Therapeutics 01/2022 - 02/2006
9	Injections 10/2023 - 01/2010
3	Lasers (Laser) 01/2018 - 01/2014
3	Filtering Surgery 12/2016 - 01/2012
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2018
2	Intravitreal Injections 01/2014 - 09/2012
1	Drug Tapering 01/2023
1	Preoperative Period 12/2018
1	Phacoemulsification 12/2018
1	Light Coagulation 01/2014
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/2012
1	Vitrectomy 06/2012